Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment

Area of Science:

• Neuroscience
• Medical Imaging
• Neurology

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques and neurodegeneration.
• Understanding the interplay between Aβ accumulation and brain metabolism is crucial for early diagnosis and treatment.

Purpose of the Study:

• To investigate the longitudinal relationship between brain amyloid burden and glucose metabolism in individuals with mild cognitive impairment (MCI) who progress to AD.
• To explore potential compensatory mechanisms in brain metabolism during the early stages of AD.

Main Methods:

• Longitudinal positron emission tomography (PET) study design.
• Utilized [11C]PIB PET to quantify amyloid burden and [18F]FDG PET to measure brain glucose metabolism.
• Included nine MCI patients who converted to AD and nine healthy controls, with scans at baseline and 5-year follow-up.

Main Results:

• Higher baseline [11C]PIB uptake in MCI patients compared to controls, with widespread cortical spread upon conversion to AD.
• Reduced [18F]FDG uptake in temporal-parietal regions at baseline in MCI, progressing to widespread cortical reduction at 5 years.
• Significant reduction in posterior brain metabolism during follow-up; positive association between amyloid load and posterior metabolism in MCI, which diminished after AD conversion.

Conclusions:

• Brain amyloid accumulation and metabolism are interconnected throughout the AD disease process.
• Evidence suggests a possible compensatory upregulation of posterior brain metabolism in the early MCI phase.
• These findings highlight the dynamic relationship between Aβ pathology and neuronal function in the transition from MCI to AD.